Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Fitzgerald

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Digital Health|March 24, 2022
Public opinion of the Irish "COVID Tracker" digital contact tracing App: A national surveyMichael E O'Callaghan, Manzar Abbas, Jim Buckley, et al.
JMIR Mhealth and Uhealth|May 18, 2021
Best Practice Guidance for Digital Contact Tracing Apps: A Cross-disciplinary Review of the LiteratureJames O'Connell, Manzar Abbas, Sarah Beecham, et al.
Diabetes Care|May 18, 2021
Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 DiabetesAshby F Walker, Korey K Hood, Matthew J Gurka, et al.
Irish Journal of Medical Science|February 19, 2021
Sentiment analysis of user feedback on the HSE's Covid-19 contact tracing appKaavya Rekanar, Ian R O'Keeffe, Sarah Buckley, et al.
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trialsEdward J Gane, Stephen Pianko, Stuart K Roberts, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Digital Health|March 24, 2022
Public opinion of the Irish "COVID Tracker" digital contact tracing App: A national surveyMichael E O'Callaghan, Manzar Abbas, Jim Buckley, et al.
JMIR Mhealth and Uhealth|May 18, 2021
Best Practice Guidance for Digital Contact Tracing Apps: A Cross-disciplinary Review of the LiteratureJames O'Connell, Manzar Abbas, Sarah Beecham, et al.
Diabetes Care|May 18, 2021
Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 DiabetesAshby F Walker, Korey K Hood, Matthew J Gurka, et al.
Irish Journal of Medical Science|February 19, 2021
Sentiment analysis of user feedback on the HSE's Covid-19 contact tracing appKaavya Rekanar, Ian R O'Keeffe, Sarah Buckley, et al.
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trialsEdward J Gane, Stephen Pianko, Stuart K Roberts, et al.
Pageof 3